Prevention is better than cure
Jerusalem, Israel, August 17, 2024 : G Medical Innovations, a
cutting-edge mobile health company, proudly announces the appointment of Akash
Biomatrix Pvt. Ltd as the exclusive Master Distributor for their
flagship product, PRIZMA, in India. This strategic partnership marks a
significant milestone in the advancement of healthcare technology.
PRIZMA: Revolutionizing Remote Health Monitoring
PRIZMA, an FDA-approved portable device, empowers
users with real-time wireless monitoring of critical vital signs, including:
1. ECG (Electrocardiogram): Measures the electrical
impulses of the heart, aiding in the diagnosis of abnormal heart rhythms such
as Atrial Fibrillation.
2. Blood Pressure: Provides accurate blood pressure
readings.
3. Blood Sugar (Glucose): Monitors glucose levels for
diabetes management.
4. SPo2 (Oxygen Saturation): Tracks oxygen levels in
the blood.
Key Features of PRIZMA:
● Waterproof AI Patches: These small, waterproof
patches adhere to the user’s chest, transmitting data 24/7 to the PRIZMA device
and remote diagnostic centres. No patient cables are required!
● Real-Time Remote Diagnostics: AI-enabled algorithms
analyze data, providing early warnings and alerts for impending cardiovascular
events.
● User-Friendly: PRIZMA is easy to apply, requires no
cell phone pairing.
● Certified Cardiac Technicians: Continuous
monitoring by certified cardiac technicians ensures accurate analysis.
● Multi-Channel ECG: PRIZMA’s multi-channel extended
Holter records every heartbeat, enhancing diagnostic accuracy.
● High Patient Compliance: Comfortable and stress-free
monitoring encourages patient adherence.
Saving Lives, One Alert at a Time
By detecting cardiovascular events early, PRIZMA has
the potential to save countless lives. The future of remote health monitoring
is here, and G Medical Innovations and Akash Biomatrix are at the forefront.
Prizma Care – A Revolutionary Ecosystem for Remote
Patient Monitoring
An innovative ecosystem that can monitor patients’ vital signs remotely and reliably,detect and notify any abnormalities in heart rate, ECG, blood pressure, Oxygen saturation, or weight and save lives by enabling timely interventions and prevention.
G Medical G Patch
FDA approved Pediatrics and Adults G Patch (AECG) is proven
to increase patient comfort and compliance. The “snap, peel, and stick”
application enables stress- free monitoring. Its Ultra-compact design and
comfortable format increase patient compliance. Worn from 72 hours and up to 14
days It continuously records a 2 or 3-channel ECG.
Potential Market Size of Personal Portable Medical
Diagnostics in India
The personal portable medical diagnostics sector in India
shows great promise due to health-conscious consumers and technological
advancements.
1. Market Size: In 2023, the Indian diagnostics
market was valued at $13 billion and is projected to reach $26 billion by
2028.
2. Growth Drivers: Chronic diseases, an aging
population, and increased health awareness are driving growth.
3. Forecasts: The Indian diagnostic lab market is predicted
to reach $44.92 billion by 2032, with another estimate projecting $20
billion by 2026.
Dr. Yacov Geva, CEO of G Medical Innovations,
expressed enthusiasm about the collaboration: “Our mission is to transform
healthcare through innovative solutions. With Akash Biomatrix’s expertise and
reach in India, PRIZMA will empower patients and healthcare providers alike.”
Mr. Niv Geva said: “We, at G Medical Innovations, are
extremely excited to market Prizma in the multi Billion Dollar market in South
Asia and particularly India.“
Dr. Yacov Geva added: “Even if we tap into a small
market share in India, It will translate into hundreds of Millions in revenue.”
About G Medical Innovations: G Medical Innovations is
a next-generation mobile health company that develops and markets clinical and
consumer medical-grade health monitoring solutions, offering end-to-end support
for e health projects.
For more information, visit G Medical Innovations or
PRIZMACare23.
About Akash Biomatrix Pvt. Ltd: Akash Biomatrix Pvt.
Ltd, headquartered in Mumbai, India, is a leading healthcare solutions provider
committed to improving patient outcomes through cutting-edge technologies.
For media inquiries, please contact: Press Relations Email: info@akashbiomatrix.com,
info@globaloneindia.com Mob: +91-9137371062,
+91-9359781225
Disclaimer: This press release is for informational
purposes only and does not constitute medical advice.
Note: This press release contains forward-looking
statements. Actual results may vary based on market conditions and regulatory
approvals.